Biomarkers play a central role in the preoperative assessment of cardiovascular risk to prevent postoperative morbidity and mortality.
Novel biomarkers may refine preoperative cardiovascular risk assessment; leaves open prospective validation before clinical adoption.
Preoperative assessment of cardiovascular risk and timely diagnosis of myocardial damage are of great importance in the prevention of postoperative morbidity and mortality. The latest guidelines by the European Society of Cardiology (ESC) / European Society of Anesthesiology (ESA) emphasize the importance of the anesthesiologist in the multidisciplinary approach as well as the central role of biomarkers in the preoperative preparation of patients. In addition to the standard battery of biomarkers, which has been used for years to assess the cardiovascular risk, there are new biomarkers which promise more accurate and more specific preoperative assessment. Acta Medica Medianae 2016;55(1):70-75.
No takes yet. Share an insight, caveat, or question.
Marković et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: